ethinyl estradiol has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hindsberger, C; Jacobsen, LV; Vouis, J; Zdravkovic, M | 1 |
| Bush, M; Lewis, E; Scott, R; Watanalumlerd, P; Zhi, H | 1 |
2 trial(s) available for ethinyl estradiol and glucagon-like peptide 1
| Article | Year |
|---|---|
Treatment with liraglutide--a once-daily GLP-1 analog--does not reduce the bioavailability of ethinyl estradiol/levonorgestrel taken as an oral combination contraceptive drug.
Topics: Aged; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Levonorgestrel; Liraglutide; Middle Aged; Postmenopause | 2011 |
Effects of multiple doses of albiglutide on the pharmacokinetics, pharmacodynamics, and safety of digoxin, warfarin, or a low-dose oral contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral; Digoxin; Drug Interactions; Ethinyl Estradiol; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Male; Middle Aged; Norethindrone; Warfarin; Young Adult | 2012 |